@juxtaposer You do know that Starpharma or a partner are at least 4 years away from even submitting a new drug application (NDA) ? And that is dependent on ‘somebody’ conducting a successful Phase 3 trial which could possibly commence next year if DEP is licenced or alternatively SPL conduct a huge capital raising.
